Regeneron Pharmaceuticals, Inc.
Sound Shore initiated Regeneron when the shares traded at roughly 13 times earnings with an 8% free-cash-flow yield. The company has a fortress balance sheet and a pipeline with…
REGN
3 published ideas on Regeneron Pharmaceuticals, Inc. across 2 funds — 3 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Regeneron Pharmaceuticals, Inc.: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Sound Shore initiated Regeneron when the shares traded at roughly 13 times earnings with an 8% free-cash-flow yield. The company has a fortress balance sheet and a pipeline with…
Sound Shore initiated Regeneron when the shares traded at roughly 13 times earnings with an 8% free-cash-flow yield. The company has a fortress balance sheet and a pipeline with…
The fund added to Regeneron because the stock ranked highly on cash flow and forecast earnings measures, two of LSV's most important valuation factors. Management has been…